Cytokinetics CYTK
NASDAQ CYTK
$65.64 -0.52 (-0.79%)
At close: Sep 29, 2026 · 4:00 PM EDT

Cytokinetics (CYTK) Research & Development (2010 - 2026)

Updated

Cytokinetics (CYTK) recorded Research & Development of $97.81 million in Q2 2026, down 11.2% from $110.14 million a year earlier but up 2.4% from the prior quarter.

Analysis

Cytokinetics (CYTK) Research & Development (2010 - 2026) Analysis & Trends

On a TTM basis, Cytokinetics' Research & Development came in at $396.96 million as of Jun 30, 2026, up 2.7% year-over-year; for FY2025, it was $416.03 million, up 22.6% from FY2024.

  • Annual Research & Development has increased for six straight years, with a five-year compound annual growth rate of 33.8% (FY2020 to FY2025).
  • Across earlier years, Research & Development came in at $339.41 million in FY2024 (+2.8%), $330.12 million in FY2023 (+37.1%), $240.81 million in FY2022 (+50.6%) and $159.94 million in FY2021 (+65.0%).
  • Quarterly Research & Development has ranged from $43.5 million in Q4 2021 to $110.14 million in Q2 2025 over the past five years.
  • On a year-over-year basis, Research & Development rose in six of the last eight quarters, with growth averaging 10.8%.
  • Peak year-over-year performance for Research & Development in the last five years was growth of 100.1% in Q3 2021, against a decline of 11.2% in Q2 2026 at the low end.
  • Per Business Quant, the preceding three quarters came in at $95.53 million (Q1 2026), $104.4 million (Q4 2025) and $99.23 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) R&D (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 3.65 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn 2.34 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn 9.74 Bn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn -2.85 Bn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn -4.05 Bn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 1.87 Bn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn 1.76 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 2.81 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn 993.80 Mn
10 Cytokinetics 9.20 Bn 5.37 Bn 25.89 Mn 97.81 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 97.81 Mn
Mar 31, 2026 95.53 Mn
Dec 31, 2025 104.40 Mn
Sep 30, 2025 99.23 Mn
Jun 30, 2025 110.14 Mn
Mar 31, 2025 98.26 Mn
Dec 31, 2024 93.63 Mn
Sep 30, 2024 84.61 Mn
Jun 30, 2024 79.60 Mn
Mar 31, 2024 81.57 Mn
Dec 31, 2023 84.98 Mn
Sep 30, 2023 82.53 Mn
Jun 30, 2023 83.19 Mn
Mar 31, 2023 79.42 Mn
Dec 31, 2022 75.02 Mn
Sep 30, 2022 62.73 Mn
Jun 30, 2022 57.13 Mn
Mar 31, 2022 45.94 Mn
Dec 31, 2021 43.50 Mn
Sep 30, 2021 48.44 Mn
API Access

Cytokinetics Research & Development API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=research-and-development&ticker=CYTK&period=max&api_key=YOUR_API_KEY